Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US OTC Oral Phenylephrine GRASE Meeting Stretched To Two Days In Rescheduled NDAC

Jun 15 2023

• By Malcolm Spicer

• Source: HBW Insight/Malcolm Spicer

Related Content

Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC

Dec 17 2007

Citizen Petition On Phenylephrine Requests Pulling OTC Status For Children

Feb 12 2007

Pseudoephedrine Will Be Behind The Counter Across The Country By October

Mar 06 2006

Study Stirs Doubts On Phenylephrine, Questions On Monograph Process

Oct 26 2015

Petition Answers FDA Questions On Oral Phenylephrine Efficacy, Suggests Removal From Monograph

Nov 09 2015

US FDA Postpones Advisory Panel Meeting On Oral Phenylephrine GRASE

Mar 22 2023

Additional Topics

International United States Advisory Committees FDA OTC Drugs Advertising, Marketing & Sales Commercial Compliance Consumer Drug Approval Standards Drug Review Drug Safety Ingredients Policy Regulation Safety

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window